Pharmacokinetics of ceftazidime, alone or in combination with piperacillin or tobramycin, in the sera of cancer patients.

We administered 2 g of ceftazidime intravenously every 8 h to cancer patients for the empiric therapy of febrile episodes. Ceftazidime was administered as monotherapy for patients with granulocyte counts in excess of 1,000/microliter. Febrile, neutropenic patients were randomized to also receive eit...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Drusano, G L, Joshi, J, Forrest, A, Ruxer, R, Standiford, H, Leslie, J, Wade, J, Schimpff, S
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1985
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC180104/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3890730/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.27.4.605
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!